A GROUNDBREAKING cancer vaccine could stop tumours growing in patients with advanced disease, researchers say. Designed to ...

Prostate cancer affects about 1 in 8 men in the United States. Highly treatable when caught early, regular screenings for ...

A wide selection of therapies are available to treat advanced prostate cancer, but the optimal treatment strategy is unknown.

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer ...

Treatment-resistant cells are a challenge related to prostate cancer and many other cancers, which arises as the disease ...

By tracking the changes in prostate cancer cells over time, researchers have found that activation of the MYC gene -- a well-known cancer-causing gene -- sets off a cascade of events that leads to ...

Annexuzlimab is under clinical development by MedAnnex and currently in Phase I for Prostate Cancer. According to GlobalData, Phase I drugs for Prostate Cancer have a 76% phase transition success rate ...

"We have cases in the hospitals that there are those patients, younger patients less than 40 years old, less than 45 years ...

By Stephen Strup UK Healthcare Prostate cancer is one of the most common cancers affecting men and the second-leading cause of cancer-related deaths among men in the U.S. While early detection can ...

NSD-2 is crucial for AR activity in prostate cancer, promoting tumor growth and offering a potential therapeutic target for advanced prostate cancer treatment.

KETV NewsWatch 7 discussed the signs and prevention with Dr. Joan Delto, a urologist and associate professor with CHI Health ...

There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully ...